"The Food and Drug Administration’s (FDA) update today stating that although silicone breast implants have “a reasonable assurance of safety … the longer a woman has breast implants, the more likely she is to experience local complications or adverse outcomes,” is unquestionably shortsighted as well as contradictory.

Public Citizen continues to oppose the FDA’s 2006 decision to return silicone breast implants to the market for cosmetic use in women for augmentation.

The agency’s newer information about the risk of implant-associated lymphoma and the previously known risks are serious enough to warrant advising women against having these implanted."